Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 43 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,211 | +14.6% | 22,057 | +42.8% | 0.00% | – |
| Q2 2023 | $104,865 | -65.8% | 15,444 | -74.8% | 0.00% | -100.0% |
| Q1 2023 | $306,938 | +121.9% | 61,265 | +116.2% | 0.00% | – |
| Q4 2022 | $138,314 | -7.2% | 28,343 | +175.2% | 0.00% | -100.0% |
| Q3 2022 | $149,000 | -86.0% | 10,300 | -74.2% | 0.00% | -75.0% |
| Q3 2018 | $1,063,000 | – | 40,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $932,939 | 3.08% |
| Sofinnova Investments, Inc. | 2,194,278 | $10,708,077 | 0.64% |
| Artal Group S.A. | 400,000 | $1,952 | 0.11% |
| Polar Capital Holdings Plc | 1,991,929 | $9,720,614 | 0.08% |
| ASHFORD CAPITAL MANAGEMENT INC | 98,870 | $482,486 | 0.08% |
| Soleus Capital Management, L.P. | 87,182 | $425,448 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 99,160 | $484 | 0.06% |
| Cormorant Asset Management, LP | 150,000 | $732 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 48,233 | $235,377 | 0.04% |
| XTX Topco Ltd | 38,574 | $188,241 | 0.04% |